-
From the Editor-in-Chief
Immunotherapy Gets PersonalTherapeutic vaccines can stimulate an immune response to cancer.
by William G. Nelson, MD, PhD
-
Forward Look
The Promise of Liquid BiopsiesBlood tests that detect traces of cancer cells and tumor DNA help find residual disease after treatment is completed.
by Tara Haelle
-
Forward Look
Should Race Inform Screening Recommendations?Study suggests incorporating race and ethnicity in age-based breast cancer screening guidelines.
by Darcy Lewis
-
Forward Look
Diaphragm DisturbancesHiccups are a common and underreported side effect of some cancer treatments.
by Carolyn Bernhardt
-
Immunotherapy: When Is Sooner Better Than Later?Researchers explore whether giving immunotherapy before surgery and other treatments could improve outcomes for people with cancer.
by Stephen Ornes
-
Living With Chronic Blood CancerThanks to medical advances, more people with blood cancer are living for years or even decades after their diagnosis. But when these diseases are incurable, patients must learn to adjust to ongoing monitoring and treatment.
by Kendall K. Morgan
-
Facts and Stats
Will We Make the Moonshot?As the Cancer Moonshot aims to cut cancer deaths in half by 2047, researchers identify strategies to hit that benchmark.
by Thomas Celona
-
Drop in Cancer Diagnoses Under COVID-19 Raises AlarmsResults of a recent study support concerns that pandemic disruptions resulted in finding fewer cancers.
by Kyle Bagenstose
-
Choosing Between Lung Cancer Surgery and RadiationStudy suggests surgery leads to longer survival than radiation for non-small cell lung cancer, but radiation remains an important option.
by Jon Kelvey
-
Understanding Disparities in Melanoma DiagnosisBlack men with melanoma are more likely than other populations to die of the disease. Here’s why, and what to look for.
by Kyle Bagenstose
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
